EP2583758A1 — Manually operable fluid dispensing device
Assigned to Lek Pharmaceuticals dd · Expires 2013-04-24 · 13y expired
What this patent protects
Manually operable fluid dispensing device, comprising: a housing (10a, 10b; 110; 210), an actuation member (30; 130; 230) attached to the housing (10a, 10b; 110; 210) so that it can be manually actuated in an actuation direction, a movable member (20; 120; 220) being movable in a…
USPTO Abstract
Manually operable fluid dispensing device, comprising: a housing (10a, 10b; 110; 210), an actuation member (30; 130; 230) attached to the housing (10a, 10b; 110; 210) so that it can be manually actuated in an actuation direction, a movable member (20; 120; 220) being movable in a direction substantially perpendicular to the actuation direction of the actuation member (30; 130; 230) in order to enable a discharge of fluid from the fluid dispensing device, a conversion mechanism for converting a movement of the actuation member (30; 130; 230) into a movement of the moveable member, wherein the conversion mechanism includes a flexible member (40; 140; 240) being elastically deformable, the flexible member (40; 140; 240) being in engagement with the movable member (20; 120; 220) and supported by the actuation member (30; 130; 230) such that it is able to elastically deform in connection with an actuation of the actuation member (30; 130; 230), the flexible member (40; 140; 240) applying a force onto the movable member (20; 120; 220) for moving the movable member (20; 120; 220).
Drugs covered by this patent
- Arnuity Ellipta (FLUTICASONE FUROATE) · Haleon Us Holdings
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.